Skip to content

Clinical and mechanistic studies on Zuo Gui Wan and its additive formula to promote neurovascular regeneration and repair after ischemic stroke

Clinical and mechanistic studies on Zuo Gui Wan and its additive formula to promote neurovascular regeneration and repair after ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000588
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Test Group:Zuo Gui Pill
Control Group:Conventional treatment with modern medicine
Test Group:Brain Rejuvenation Formula
Test Group:Zuogui Tongluo Formula

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. meet the diagnostic criteria of stroke disease and the identification criteria of liver and kidney yin deficiency and subordinate patterns (including kidney deficiency and phlegm obstruction, kidney deficiency and blood stasis) in Chinese medicine. 2. aged between 40 and 80 years old, gender is not limited. 3. Acute onset of the disease, with a duration of 7-14 days. 4. The longest diameter of the infarct is about 1.5cm-5cm; 5. presence of limb motor dysfunction, but no cognitive impairment, assessed NIHSS score =4, mRS score =3; 6. can understand and follow simple instructions from the therapist 7. give informed consent and volunteer to be tested. The process of obtaining informed consent should be in accordance with GCP.

Exclusion criteria

Exclusion criteria: 1. Those suffering from other diseases that can cause motor dysfunction (e.g. Parkinson's disease, brain tumour, hepatomegaly, etc.). 2. Those with unstable vital signs; those with bleeding tendency. 3. Combined serious medical diseases (e.g. heart, liver, kidney and other important organ failure, atrial fibrillation, pulmonary embolism). 4. Post-stroke depression or severe aphasia. 5. Combined with conscious coma, dementia, vegetative state or mental abnormality. 6. Those who are unable to complete the magnetic resonance examination (e.g. pacemaker implantation, metal implantation in the body).

Design outcomes

Primary

MeasureTime frame
Fugl Meyer Assessment;Modified Rankin Rating Scale;

Secondary

MeasureTime frame
National Institute of Health stroke scale;Haematological marker;Modified Barthel Index;Chinese Medicine Score;

Countries

China

Contacts

Public ContactWeilei Li

Jiangsu Province Hospital of Chinese Medicine

yfy120@njucm.edu.cn13951039736

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026